AC
AZN icon

Avestar Capital’s AstraZeneca AZN Stock Holding History

Avestar Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
6,836
+349
+5% +$65.6K 0.07% 197
2026
Q1 		$1.27M Sell
6,487
-530
-8% -$102K 0.08% 184
2025
Q4 		$1.29M Sell
7,017
-31
-0.4% -$5.44K 0.08% 183
2025
Q3 		$1.08M Sell
7,048
-30
-0.4% -$4.54K 0.07% 205
2025
Q2 		$989K Sell
7,078
-649
-8% -$91K 0.07% 214
2025
Q1 		$1.14M Buy
7,727
+13
+0.2% +$1.88K 0.1% 174
2024
Q4 		$1.01M Buy
7,714
+1,231
+19% +$172K 0.09% 171
2024
Q3 		$1.01M Buy
6,483
+224
+4% +$36.2K 0.1% 153
2024
Q2 		$976K Buy
6,259
+3,520
+129% +$530K 0.1% 153
2024
Q1 		$371K Buy
2,739
+308
+13% +$40.8K 0.04% 287
2023
Q4 		$327K Buy
2,431
+18
+0.7% +$2.34K 0.04% 279
2023
Q3 		$327K Buy
2,413
+48
+2% +$6.56K 0.05% 230
2023
Q2 		$338K Buy
2,365
+101
+4% +$14.9K 0.05% 208
2023
Q1 		$314K Buy
+2,264
New +$305K 0.06% 223
2021
Q4 		– Sell
-1,688
Closed -$203K – 431
2021
Q3 		$203K Hold
1,688
– – 0.03% 433
2021
Q2 		$202K Buy
+1,688
New +$185K 0.03% 424
2020
Q4 		– Sell
-2,945
Closed -$313K – 269
2020
Q3 		$313K Buy
+2,945
New +$328K 0.1% 152
2019
Q3 		– Sell
-1,147
Closed -$92K – 228
2019
Q2 		$92K Hold
1,147
– – 0.06% 204
2019
Q1 		$89K Buy
1,147
+323
+39% +$25.5K 0.06% 205
2018
Q4 		$59K Buy
824
+46
+6% +$3.59K 0.04% 242
2018
Q3 		$59K Buy
778
+238
+44% +$18K 0.03% 258
2018
Q2 		$34K Sell
540
-23
-4% -$1.66K 0.02% 304
2018
Q1 		$36K Sell
563
-140
-20% -$9.7K 0.02% 276
2017
Q4 		$46K Buy
+703
New +$47.4K 0.03% 257

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Avestar Capital's AZN Position: Q2 2026 in Review

Avestar Capital increased its AstraZeneca (AZN) stake by 5.4% in Q2 2026, buying an estimated $65.6K and bringing the position to 6,836 shares worth $1.29M. The position accounts for 0.07% of the portfolio, ranked #197.

Avestar Capital first reported a position in AZN in Q4 2017 and has held it in 24 quarters since. The position peaked at $1.29M in Q4 2025. 646 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Avestar Capital held 6,836 shares of AstraZeneca worth $1.29M as of Q2 2026.
  • Avestar Capital bought 349 AstraZeneca shares in Q2 2026, an estimated $65.6K.
  • AstraZeneca made up 0.07% of Avestar Capital's portfolio in Q2 2026, its #197 holding.
  • Avestar Capital first reported a position in AstraZeneca in Q4 2017 and has held it in 24 quarters since.
  • Avestar Capital's AstraZeneca position peaked at $1.29M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.